DOJ Charges 200 Defendants in $2.7 Billion Pandemic Fraud Crackdown

Federal prosecutors have charged approximately 200 defendants in a coordinated crackdown on pandemic-era healthcare fraud spanning five states, with schemes totaling more than $2.7 billion, according to the U.S. Department of Justice.

The November 4, 2024 enforcement action—described by officials as one of the most significant healthcare fraud operations since COVID-19 relief funds began flowing in 2020—targeted Texas, California, Florida, New York, and Illinois, states that received the largest share of federal relief disbursements and generated the highest volumes of fraudulent healthcare billing claims during the pandemic.

This latest action builds on years of federal prosecutions. Since 2021, pandemic-related fraud enforcement has resulted in more than 3,000 defendants charged and $1.4 billion in stolen funds seized, according to the DOJ.

The current sweep is distinct from an earlier milestone when U.S. Attorney Markenzy Lapointe of the Southern District of Florida announced a separate action charging 193 defendants involved in over $2.75 billion in false claims, as documented by FBI Miami.

Federal investigators have identified recurring patterns across jurisdictions, including claims for services never rendered, fabricated patient records, and enrollment of fictitious or deceased individuals in federal benefit programs to generate fraudulent reimbursements.

The legal framework for these coordinated prosecutions traces back to May 26, 2021, when the DOJ established its multi-district task force model that prosecutors now deploy across jurisdictions simultaneously.

Texas has emerged as the most active enforcement jurisdiction in the current sweep, with multiple U.S. Attorney offices filing charges simultaneously. In the Western District of Texas, one defendant received a 14-year federal prison sentence for leading a $68.5 million healthcare fraud scheme that involved submitting fraudulent claims to federal healthcare programs.

In a particularly disturbing Northern District case, a mother was sentenced to 17 years in federal prison for a fraud scheme involving her quadriplegic son. Prosecutors described the scheme as a sustained exploitation of Medicaid home health benefits, with the defendant submitting false claims for care never provided to her son.

Another notable Texas case involved Kimionte Bennett, 30, of Waxahachie, who received 70 months for a $1.7 million SIM card swapping scheme. Unlike defendants who submitted fraudulent paperwork, Bennett allegedly hijacked victims’ phone numbers by convincing wireless carriers to transfer SIM cards, then bypassed two-factor authentication to redirect pandemic relief payments.

In the Southern District of Texas, a Houston resident received a decade in prison for laundering proceeds from a $40 million fraud scheme based on false loan applications. Healthcare employees in the same district received prison sentences for a $12.5 million adult daycare fraud scheme billing Medicare and Medicaid for services that were either never provided or provided to unqualified individuals.

The prosecutorial strategy reflects a deliberate approach refined over four years of pandemic fraud litigation. Rather than allowing individual U.S. Attorney offices to pursue cases in isolation, the November 2024 action coordinated simultaneous charging decisions across jurisdictions to prevent defendants from exploiting gaps between district-level enforcement priorities.

Prosecutors have built cases using financial records from banks, payment processors, and federal program administrators. In healthcare fraud cases, they typically rely on Medicare and Medicaid claims data to identify billing anomalies, such as claims for impossible service volumes, deceased patients, or procedures requiring equipment the provider doesn’t possess.

The $2.7 billion total associated with the current action represents the aggregate value of false claims and fraudulent applications submitted by charged defendants—not necessarily the amount actually paid out by federal programs. In healthcare fraud cases, the amount billed often exceeds the amount reimbursed because program administrators reject some claims during routine processing.

Federal officials acknowledge the gap between stolen funds and recovered amounts. The Government Accountability Office has estimated that pandemic relief programs disbursed between $100 billion and $135 billion in potentially fraudulent payments, far exceeding the amounts charged in any single enforcement action.

While Texas has generated the most publicly documented individual cases, California, New York, and Illinois each contributed significant charging activity. California’s inclusion reflects its status as the largest recipient of PPP loan funds and Medicaid reimbursements during the pandemic period. New York cases focused heavily on the intersection of healthcare fraud and identity-based schemes. Illinois cases centered on the Chicago metropolitan area, where investigators identified networks of providers submitting coordinated false claims to multiple federal programs simultaneously.

Federal investigators have indicated that the current 200-defendant action doesn’t represent the full scope of ongoing pandemic fraud investigations. Additional charges are expected as investigations initiated in 2021 and 2022 reach the charging stage.

Asset recovery remains a central focus of post-charging proceedings. In cases where defendants have already spent or transferred fraud proceeds, prosecutors pursue forfeiture of substitute assets—property of equivalent value that can be seized even if the original stolen funds are no longer traceable.

The scale of pandemic-era fraud has no precise historical parallel in American law enforcement. The speed with which pandemic relief programs were designed and deployed created structural vulnerabilities that fraudsters exploited almost immediately. Programs like PPP were designed to disburse funds within days of application approval, with verification following disbursement rather than preceding it.

For the approximately 200 defendants named in the current action, some will negotiate plea agreements while others will contest charges at trial. All are presumed innocent until proven guilty. However, the pattern of prior pandemic fraud prosecutions—in which the overwhelming majority of charged defendants have ultimately been convicted—suggests federal prosecutors entered this action with substantial confidence in their evidence.

Texas, California, Florida, New York, and Illinois will continue to be the primary battlegrounds for pandemic fraud litigation for the foreseeable future, generating legal precedent that will shape how pandemic fraud—and future emergency relief fraud—is prosecuted for years to come.